Cell therapy for bone nonunion: a retrospective study.

医学 骨不连 间充质干细胞 脐带 外科 骨愈合 骨髓 外周血单个核细胞 移植 内科学 病理 免疫学 生物 生物化学 体外
作者
Zhiguo Qu,Guojun Fang,Zhenghong Cui,Y Liu
出处
期刊:PubMed [National Institutes of Health]
卷期号:106 (6): 315-321 被引量:20
链接
标识
摘要

AIM: The aim of this study was to report our experience in augmenting nonunion both with bone marrow mononuclear cells/mesenchymal stem cells (MSCs) and conventional surgical approaches; and for clinical applications, a simple, safe, and reproducible method to effectively treat bone mass loss disease. METHODS: A retrospective analysis was performed on stem cell-treated bone nonunion patients from October 1, 2007 to October 1, 2009. Nine patients were categorized into two groups: group 1 consists of 3 patients who received autologous bone marrow mononuclear cells transplantation; group 2 consists of 6 patients who received umbilical cord MSCs (hUC-MSCs) transplantation. All patients accepted conventional surgical treatment and X-ray supervised at 3, 6, and 12 months or so after transplantation, while T cells' subtype was analyzed. RESULTS: All patients were followed up for 36 months through recheck Out-patient Department and X-ray examination to observe the fracture healing. The mean time for clinical healing was comparable in both groups. The mean time of fracture lines blurred partly, continuous bone callus formation, marrow flow was 3.5M, 6.2M, and 9.1M, respectively, in the human umbilical cord mesenchymal stem cells (hUC-MSCs) treatment group. The compared healing times were 3.8 M, 7.1M and 10.6 months in autologous bone marrow mononuclear cells transplantation, respectively. The serum levels of CD4, CD56, and HLA-DR in hUC-MSCs graft group were negative, while the serum level of CD8 was 7.8% positive. Clearly, there was no significant difference in the percent of T subsets between the 2 groups of T cells' subtype. CONCLUSION: Our study showed that patients treated by allograft-augmentation had no complications, reduced treatment- dissatisfaction. The use of hUC-MSCs should be offered to suitable patients in the preoperative consultation as a valuable alternative for autologous grafting and larger clinical trials should be considered in the future.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LJN.up完成签到,获得积分10
刚刚
whiteandpink098完成签到,获得积分10
1秒前
梵羽发布了新的文献求助10
1秒前
2秒前
LJN.up发布了新的文献求助10
2秒前
GTY完成签到,获得积分10
3秒前
苹果星月发布了新的文献求助20
7秒前
无糖可乐完成签到,获得积分10
7秒前
Glllll完成签到 ,获得积分10
8秒前
传奇3的应助被张点心采纳,获得10
8秒前
慈蔼的人完成签到 ,获得积分10
9秒前
共享精神的应助被十七采纳,获得10
9秒前
谨慎笑阳完成签到,获得积分10
9秒前
小胡完成签到,获得积分10
10秒前
Running发布了新的文献求助10
10秒前
景琦完成签到,获得积分10
10秒前
29完成签到,获得积分10
10秒前
10秒前
12秒前
13秒前
XZJ完成签到,获得积分10
14秒前
heiehi完成签到,获得积分10
14秒前
14秒前
14秒前
搜集达人的应助被明前易拉罐采纳,获得10
15秒前
高山完成签到 ,获得积分10
16秒前
Tao完成签到 ,获得积分10
17秒前
Jaylou完成签到,获得积分0
17秒前
18秒前
充电宝的应助被MADAO采纳,获得30
18秒前
上官若男的应助被青小泥采纳,获得10
18秒前
xing发布了新的文献求助10
18秒前
万能图书馆的应助被左白易采纳,获得10
19秒前
OS完成签到 ,获得积分10
19秒前
19秒前
陈晓钱完成签到,获得积分10
21秒前
21秒前
22秒前
xiaoxia完成签到,获得积分10
22秒前
DUMPLINGS完成签到 ,获得积分10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571537
关于积分的说明 21818552
捐赠科研通 7778091
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479621